Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S1 from Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial
  1. Home
  2. Publications
  3. Supplementary Table S1 from Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial

Supplementary Table S1 from Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial

Authors:
  • FMFederica Miglietta
    Federica Miglietta
  • MGManon De Graaf
    Manon De Graaf
  • CVClaudio Vernieri
    Claudio Vernieri
  • FPFederico Piacentini
    Federico Piacentini
  • MCMatilde Cacciatore
    Matilde Cacciatore
  • ABAndrea Botticelli
    Andrea Botticelli
  • AVAndrea Vingiani
    Andrea Vingiani
  • GFGiuseppe Fotia
    Giuseppe Fotia
  • LNLorenzo Nicolè
    Lorenzo Nicolè
  • GGGaia Griguolo
    Gaia Griguolo
  • TGTommaso Giarratano
    Tommaso Giarratano
  • DMDavide Massa
    Davide Massa

Open Access
Publisher website
Google Scholar
  • 15 December 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30882877
Abstract
Clinicopathological features according to ER expression in the TONIC trial cohort Clinicopathological features of patients in the TONIC trial cohort, reported according to ER expression status (ER-low vs ER-0).
Keywords
  • BIOMARKERS
  • PROGNOSTIC BIOMARKERS
  • BREAST CANCER
  • IMMUNOTHERAPY
  • CHECKPOINT BLOCKADE
  • TUMOR HETEROGENEITY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.